Clinical Trials Browser

Oropharyngeal Neoplasms

Astrocytoma, Glioblastoma, Gliosarcoma

Pancreatic Neoplasms

Rectal Neoplasms

Prostatic Neoplasms

Colorectal Neoplasms

Glioma, Central Nervous System Neoplasms

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Mouth Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Advanced Biliary Tract Carcinoma

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Clinical Stage I Gastric Cancer AJCC v8

Glioblastoma

Hyperthermia, Sarcoma

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Hypopharyngeal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Rhabdomyosarcoma

Carcinoma, Basal Cell, Skin Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Endometrioid Endometrial Cancer

Advanced Head and Neck Squamous Cell Carcinoma

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer

Carcinoma, Hepatocellular

Brain Neoplasms, Craniopharyngioma

Carcinoma, Hepatocellular

Triple Negative Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Locally Advanced Rectal Adenocarcinoma

Colonic Neoplasms

Carcinoma, Non-Small-Cell Lung

Rectal Neoplasms

Clinical Trials

MINT-2

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

REGINA

SUGAR

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

NBI-CAB

IVIM & OLINK in Sarcoma

GIVEN

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

N-PLANC

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

InDuRanS

ROSETTE

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

ILDR-03

HORIZON

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

TNT-HYPE

BOOST

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

SONIB

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

SENIOR-HN

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

PRISM

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

SIB-NCRT-pumch

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

SURGAN-TKI

STAR